HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nenad Stojiljkovic Selected Research

Neoplasms (Cancer)

2/2021Impact of ellagic acid application on doxorubicin-induced cardiovascular toxicity model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nenad Stojiljkovic Research Topics

Disease

5Acute Kidney Injury (Acute Renal Failure)
01/2012 - 06/2008
4Infections
01/2017 - 01/2009
2Necrosis
01/2018 - 04/2012
1Cardiovascular Diseases (Cardiovascular Disease)
02/2021
1Neoplasms (Cancer)
02/2021

Drug/Important Bio-Agent (IBA)

8Gentamicins (Gentamicin)FDA LinkGeneric
01/2017 - 06/2008
5Anti-Bacterial Agents (Antibiotics)IBA
04/2012 - 06/2008
2AntioxidantsIBA
01/2018 - 01/2009
2AminoglycosidesIBA
01/2012 - 06/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2021
1Ellagic AcidIBA
02/2021
1Free RadicalsIBA
02/2021
1Antineoplastic Agents (Antineoplastics)IBA
02/2021
1Urea (Carbamide)FDA LinkGeneric
01/2018
1CreatinineIBA
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1SeleniumIBA
04/2012
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2012
1Pentoxifylline (Trental)FDA LinkGeneric
01/2009
1Therapeutic UsesIBA
06/2008